This mechanism may explain some cases of pulmonary emphysema in non-smokers (e.g., Menkes disease, environmental exposure) and provides new therapeutic targets for COPD treatment (e.g., activation of the FAK pathway) [142]. Here, PTK2 is linked to pulmonary emphysema.